Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Seroprevalence of hepatitis B infection in Turkish children

  • 31 Accesses

  • 4 Citations

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Koff, R. S.: Hepatitis B today: clinical and diagnostic overview. Pediatr. Infect. Dis. J. 12 (1993) 428–432.

  2. 2.

    Skinhoj, P., Ibsern, K. K., Kryger, P.: Viral hepatitis in Danish children. Arch. Dis. Child 57 (1982) 146–148.

  3. 3.

    Papaevangelou, G., Karaboyia, P., Kyriadikow, A.: Prevalence and epidemiological significance of antibody to hepatitis B core antigen in Greece Am. J. Epidemiol. 106 (1977) 502–505.

  4. 4.

    Ruiz-Moreno, M., Garcia Aguado, J., Carreño Garcia, V., Alvarez Sala, L., Rincòn Victor, P., Lòpez-Linares del Prado, M., Bas Pèrez, C.: Prevalence of hepatitis caused by A, B and D virus in children. An. Exp. Pediatr. 29 (1988) 357–362.

  5. 5.

    Bruguera, M., Sànchez Tapias, J. M.: Epidemiologia de la hepatitis B en España. Med. Clin. (Barcelona) 95 (1990) 470–475.

  6. 6.

    Çakaloĝlu, Y., Ökten, A., Yalçin, S.: Türkiye’de hepatit B virüsü enfeksiyonu seroepidemiyolojisi. Turk. J. Gastroenterohepatol, 1 (1990) 49–52.

  7. 7.

    Kihçturgay, K., Mistik, R.: Türkiyede viral hepatitier. In:Kiliçturgay, K. (ed.): Viral hepatit 94. Nobel Tip Kitapevi, Istanbul 1994, pp. 1–14.

  8. 8.

    Akbak, M.: Hepatit B prevalansi ve bulaşmayl etkileyen faktörler. Uzaanlik tezi, A.Ü.T.F. Çocuk Saĝliĝi ve Hastalikari Kliniĝi 1997.

  9. 9.

    Temiz, I.: Trabzon bölgesinde 0–12 yaş çocuklarinda HBV seropozitifliĝi. Uzmanlik tezi, K.T.Ü.T.F. 1991.

  10. 10.

    Uç, A., Özsoylu, S.: Age prevalence of HBsAg positivity in children seen at Hacettepe Children’s Hospital. Turk. J. Med. Res. 10 (1992) 264–266.

  11. 11.

    Shapiro, C. N.: Epidemiology of hepatitis B. Pediatr. Infect. Dis. J. 12 (1993) 433–437.

  12. 12.

    McMahon, B. J., Alward, W. L. M., Hall, D. B., Heyward, W. L., Bender, T. R., Francis, D. P., Maynard, J. E.: Acute hepatitis B virus infection: Relation of age to the clinical expression of the disease and subsequent development of the carrier state. J. Infect. Dis. 151 (1985) 599–603.

  13. 13.

    Beasley, R. P.: Hepatitis B virus the major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942–1956.

  14. 14.

    Sobeslavsky, O.: Prevalence of markers of hepatitis B virus infection in various countries: a WHO colloborative study. Bull. WHO 58 (1980) 621–628.

  15. 15.

    Hail, C. B., Halsey, N. A.: Control of hepatitis B. Virology 16 (1985) 462–466.

  16. 16.

    Centers for Disease Control and Prevention: Hepatitis B virus: a comprehensive strategy to eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunication Practices Advisory Committee (ACIP). MMWR 40 (RR-13) (1991) 1–25.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kuyucu, N., Dökmen, A., Yöney, A. et al. Seroprevalence of hepatitis B infection in Turkish children. Infection 26, 317–318 (1998). https://doi.org/10.1007/BF02962260

Download citation

Keywords

  • Hepatitis
  • Seropositivity Rate
  • Turkish Child
  • HBsAg Positivity
  • Cotm